ACRV Acrivon Therapeutics | $7.15 +10.5% | 3/28/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | N/A | View details for HC Wainwright rating of Acrivon Therapeutics (NASDAQ:ACRV) on 3/28/2024 |
HUT Hut 8 | $11.04 +12.0% | 3/28/2024 | Target Raised by | HC Wainwright | Analyst M. Colonnese | Sell -> Sell | $7.00 -> $9.00 | N/A | View details for HC Wainwright rating of Hut 8 (NASDAQ:HUT) on 3/28/2024 |
AKBA Akebia Therapeutics | $1.83 -18.3% | 3/28/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $5.00 -> $6.00 | N/A | View details for HC Wainwright rating of Akebia Therapeutics (NASDAQ:AKBA) on 3/28/2024 |
DTIL Precision BioSciences | $13.56 +4.5% | 3/28/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $60.00 | N/A | View details for HC Wainwright rating of Precision BioSciences (NASDAQ:DTIL) on 3/28/2024 |
DRRX DURECT | $1.21 -9.7% | 3/28/2024 | Reiterated by | HC Wainwright | Analyst E. Arce | Neutral | | N/A | View details for HC Wainwright rating of DURECT (NASDAQ:DRRX) on 3/28/2024 |
CELC Celcuity | $21.60 +18.9% | 3/28/2024 | Reiterated by | HC Wainwright | Analyst S. Ramakanth | Buy -> Buy | $27.00 | N/A | View details for HC Wainwright rating of Celcuity (NASDAQ:CELC) on 3/28/2024 |
|
EFTR eFFECTOR Therapeutics | $14.39 +7.0% | 3/28/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $24.00 | N/A | View details for HC Wainwright rating of eFFECTOR Therapeutics (NASDAQ:EFTR) on 3/28/2024 |
ERAS Erasca | $2.05 -0.5% | 3/28/2024 | Reiterated by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | $8.00 | N/A | View details for HC Wainwright rating of Erasca (NASDAQ:ERAS) on 3/28/2024 |
NUVB Nuvation Bio | $3.64 -8.3% | 3/28/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $5.00 -> $8.00 | N/A | View details for HC Wainwright rating of Nuvation Bio (NYSE:NUVB) on 3/28/2024 |
KRRO Korro Bio | $90.00 +1.7% | 3/28/2024 | Target Raised by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $100.00 -> $115.00 | N/A | View details for HC Wainwright rating of Korro Bio (NASDAQ:KRRO) on 3/28/2024 |
REE REE Automotive | $5.84
| 3/28/2024 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $15.00 | N/A | View details for HC Wainwright rating of REE Automotive (NASDAQ:REE) on 3/28/2024 |
AQMS Aqua Metals | $0.54 +3.6% | 3/28/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 | N/A | View details for HC Wainwright rating of Aqua Metals (NASDAQ:AQMS) on 3/28/2024 |
SLE Super League Enterprise | $2.15 -14.0% | 3/28/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | N/A | View details for HC Wainwright rating of Super League Enterprise (NASDAQ:SLE) on 3/28/2024 |
PPTA Perpetua Resources | $4.16 +0.5% | 3/28/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.50 | N/A | View details for HC Wainwright rating of Perpetua Resources (NASDAQ:PPTA) on 3/28/2024 |
GLYC GlycoMimetics | $3.00 -5.7% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of GlycoMimetics (NASDAQ:GLYC) on 3/27/2024 |
NVCR NovoCure | $15.63 +6.8% | 3/27/2024 | Target Raised by | HC Wainwright | - | Neutral -> Neutral | $22.00 -> $24.00 | Low | View details for HC Wainwright rating of NovoCure (NASDAQ:NVCR) on 3/27/2024 |
ATAI Atai Life Sciences | $1.97 +10.1% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | N/A | View details for HC Wainwright rating of Atai Life Sciences (NASDAQ:ATAI) on 3/27/2024 |
ETNB 89bio | $11.64 +2.9% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $31.00 | Low | View details for HC Wainwright rating of 89bio (NASDAQ:ETNB) on 3/27/2024 |
CLSK CleanSpark | $21.21 -8.2% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $27.00 | Low | View details for HC Wainwright rating of CleanSpark (NASDAQ:CLSK) on 3/27/2024 |
PDSB PDS Biotechnology | $3.96 +2.9% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $21.00 | Low | View details for HC Wainwright rating of PDS Biotechnology (NASDAQ:PDSB) on 3/27/2024 |
ARGX argenx | $394.36 -1.1% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $451.00 | Low | View details for HC Wainwright rating of argenx (NASDAQ:ARGX) on 3/27/2024 |
ABOS Acumen Pharmaceuticals | $4.05 -1.2% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of Acumen Pharmaceuticals (NASDAQ:ABOS) on 3/27/2024 |
VIGL Vigil Neuroscience | $3.41 +6.6% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $24.00 | Low | View details for HC Wainwright rating of Vigil Neuroscience (NASDAQ:VIGL) on 3/27/2024 |
ANNX Annexon | $7.17 -8.2% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of Annexon (NASDAQ:ANNX) on 3/27/2024 |
WPRT Westport Fuel Systems | $6.74 -0.9% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of Westport Fuel Systems (NASDAQ:WPRT) on 3/27/2024 |
EMX EMX Royalty | $1.72 -0.6% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.50 | N/A | View details for HC Wainwright rating of EMX Royalty (NYSEAMERICAN:EMX) on 3/27/2024 |
FCUUF Fission Uranium | $0.72 -1.1% | 3/27/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $1.70 -> $1.90 | Low | View details for HC Wainwright rating of Fission Uranium (OTCMKTS:FCUUF) on 3/27/2024 |
SNDX Syndax Pharmaceuticals | $23.80 +3.2% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $41.00 | Low | View details for HC Wainwright rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 3/27/2024 |
APTO Aptose Biosciences | $1.66 +10.7% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $23.00 | Low | View details for HC Wainwright rating of Aptose Biosciences (NASDAQ:APTO) on 3/27/2024 |
DCTH Delcath Systems | $4.77 -6.3% | 3/27/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $18.00 -> $20.00 | Low | View details for HC Wainwright rating of Delcath Systems (NASDAQ:DCTH) on 3/27/2024 |
BCAB BioAtla | $3.43 -0.9% | 3/27/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $10.00 -> $7.00 | Low | View details for HC Wainwright rating of BioAtla (NASDAQ:BCAB) on 3/27/2024 |
GMAB Genmab A/S | $29.91 -2.4% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | Low | View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 3/27/2024 |
BLRX BioLineRx | $1.12 +0.9% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $21.00 | Low | View details for HC Wainwright rating of BioLineRx (NASDAQ:BLRX) on 3/26/2024 |
ATNM Actinium Pharmaceuticals | $7.83 -1.4% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | N/A | View details for HC Wainwright rating of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) on 3/26/2024 |
PRAX Praxis Precision Medicines | $61.02 +3.1% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $105.00 | Low | View details for HC Wainwright rating of Praxis Precision Medicines (NASDAQ:PRAX) on 3/26/2024 |
VKTX Viking Therapeutics | $82.00 -1.6% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $90.00 | Low | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 3/26/2024 |
BTDR Bitdeer Technologies Group | $7.02 +1.4% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Bitdeer Technologies Group (NASDAQ:BTDR) on 3/26/2024 |
APRE Aprea Therapeutics | $6.60 +8.7% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Aprea Therapeutics (NASDAQ:APRE) on 3/26/2024 |
BITF Bitfarms | $2.23 +3.2% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 | Low | View details for HC Wainwright rating of Bitfarms (NASDAQ:BITF) on 3/26/2024 |
MRNS Marinus Pharmaceuticals | $9.04 +2.1% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $27.00 | Low | View details for HC Wainwright rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 3/26/2024 |
A lot of people are making this costly mistake (Ad) You may have heard the saying “options are risky” …
And, they can be. But only if you use them the way a lot of folks do.
A lot of people think of BUYING speculative options when they talk about options.
And BUYING low probability, speculative options is definitely risky…
It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. Click here to jump in on the next one |
STRO Sutro Biopharma | $5.65 +14.6% | 3/26/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $16.00 -> $12.00 | Low | View details for HC Wainwright rating of Sutro Biopharma (NASDAQ:STRO) on 3/26/2024 |
STOK Stoke Therapeutics | $13.50 -4.7% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $35.00 | Low | View details for HC Wainwright rating of Stoke Therapeutics (NASDAQ:STOK) on 3/26/2024 |
AXSM Axsome Therapeutics | $79.80 +0.8% | 3/26/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $180.00 -> $190.00 | Low | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 3/26/2024 |
BTM Bitcoin Depot | $1.90 -0.5% | 3/26/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $5.00 -> $4.00 | Low | View details for HC Wainwright rating of Bitcoin Depot (NASDAQ:BTM) on 3/26/2024 |
ADMA ADMA Biologics | $6.60 -2.1% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 -> $7.50 | Low | View details for HC Wainwright rating of ADMA Biologics (NASDAQ:ADMA) on 3/26/2024 |
ATXS Astria Therapeutics | $14.07 +3.5% | 3/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 | Low | View details for HC Wainwright rating of Astria Therapeutics (NASDAQ:ATXS) on 3/25/2024 |
ESPR Esperion Therapeutics | $2.67 +1.9% | 3/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 | Low | View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 3/25/2024 |
IVVD Invivyd | $4.44 +11.0% | 3/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of Invivyd (NASDAQ:IVVD) on 3/25/2024 |
OTLK Outlook Therapeutics | $11.94 +27.4% | 3/25/2024 | Target Raised by | HC Wainwright | Analyst D. Tsao | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of Outlook Therapeutics (NASDAQ:OTLK) on 3/25/2024 |
RANI Rani Therapeutics | $3.11 +2.6% | 3/25/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $16.00 -> $12.00 | Low | View details for HC Wainwright rating of Rani Therapeutics (NASDAQ:RANI) on 3/25/2024 |
TIL Instil Bio | $10.80 -2.7% | 3/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 | N/A | View details for HC Wainwright rating of Instil Bio (NASDAQ:TIL) on 3/25/2024 |
BTCS BTCS | $1.76 +11.4% | 3/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of BTCS (NASDAQ:BTCS) on 3/25/2024 |
LGO Largo | $1.65 +5.8% | 3/25/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $9.00 -> $4.60 | Low | View details for HC Wainwright rating of Largo (NYSE:LGO) on 3/25/2024 |
RGLS Regulus Therapeutics | $2.88
| 3/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 | Low | View details for HC Wainwright rating of Regulus Therapeutics (NASDAQ:RGLS) on 3/25/2024 |
HOOK Hookipa Pharma | $0.71 -1.2% | 3/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.50 | Low | View details for HC Wainwright rating of Hookipa Pharma (NASDAQ:HOOK) on 3/25/2024 |
RMTI Rockwell Medical | $1.66 +1.2% | 3/25/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $11.00 -> $9.00 | Low | View details for HC Wainwright rating of Rockwell Medical (NASDAQ:RMTI) on 3/25/2024 |
RVPH Reviva Pharmaceuticals | $3.78 -3.1% | 3/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 3/25/2024 |
ABSI Absci | $5.69 +2.7% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Absci (NASDAQ:ABSI) on 3/22/2024 |
XFOR X4 Pharmaceuticals | $1.39 -1.4% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of X4 Pharmaceuticals (NASDAQ:XFOR) on 3/22/2024 |
MIST Milestone Pharmaceuticals | $1.79 -0.6% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $25.00 | Low | View details for HC Wainwright rating of Milestone Pharmaceuticals (NASDAQ:MIST) on 3/22/2024 |
CKPT Checkpoint Therapeutics | $2.05 +0.5% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $34.00 | Low | View details for HC Wainwright rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 3/22/2024 |
NXTC NextCure | $2.23 +15.2% | 3/22/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $5.00 -> $8.00 | Low | View details for HC Wainwright rating of NextCure (NASDAQ:NXTC) on 3/22/2024 |
CBUS Cibus | $22.46 +3.2% | 3/22/2024 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $25.00 | Low | View details for HC Wainwright rating of Cibus (NASDAQ:CBUS) on 3/22/2024 |
ASM Avino Silver & Gold Mines | $0.59 +0.8% | 3/22/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $1.80 -> $1.50 | Low | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 3/22/2024 |
ASM Avino Silver & Gold Mines | $0.62 +5.7% | 3/22/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $1.80 -> $1.50 | Low | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 3/22/2024 |
CABA Cabaletta Bio | $17.06 -0.5% | 3/22/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $25.00 -> $30.00 | Low | View details for HC Wainwright rating of Cabaletta Bio (NASDAQ:CABA) on 3/22/2024 |
IRON Disc Medicine | $62.31 +3.0% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $70.00 | Low | View details for HC Wainwright rating of Disc Medicine (NASDAQ:IRON) on 3/22/2024 |
ARMP Armata Pharmaceuticals | $4.18 +2.0% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | N/A | View details for HC Wainwright rating of Armata Pharmaceuticals (NYSEAMERICAN:ARMP) on 3/22/2024 |
BOLT Bolt Biotherapeutics | $1.40 +14.8% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of Bolt Biotherapeutics (NASDAQ:BOLT) on 3/22/2024 |
ASXC Asensus Surgical | $0.23 -1.7% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.00 | N/A | View details for HC Wainwright rating of Asensus Surgical (NYSEAMERICAN:ASXC) on 3/22/2024 |
OKYO OKYO Pharma | $1.49 -0.7% | 3/22/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $6.00 -> $7.00 | Low | View details for HC Wainwright rating of OKYO Pharma (NASDAQ:OKYO) on 3/22/2024 |
BLTE Belite Bio | $38.37 -3.9% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $59.00 | Low | View details for HC Wainwright rating of Belite Bio (NASDAQ:BLTE) on 3/22/2024 |
IDN Intellicheck | $3.48 -1.4% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 | Low | View details for HC Wainwright rating of Intellicheck (NYSE:IDN) on 3/22/2024 |
IFRX InflaRx | $1.54
| 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of InflaRx (NASDAQ:IFRX) on 3/22/2024 |
PYXS Pyxis Oncology | $4.26 +1.4% | 3/22/2024 | Target Raised by | HC Wainwright | Analyst S. Ramakanth | Buy -> Buy | $4.00 -> $7.00 | Low | View details for HC Wainwright rating of Pyxis Oncology (NASDAQ:PYXS) on 3/22/2024 |
MDWD MediWound | $14.25 -5.6% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $28.00 | Low | View details for HC Wainwright rating of MediWound (NASDAQ:MDWD) on 3/22/2024 |
IPHA Innate Pharma | $2.88 +21.0% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.50 | Low | View details for HC Wainwright rating of Innate Pharma (NASDAQ:IPHA) on 3/22/2024 |
ELDN Eledon Pharmaceuticals | $2.06 -3.3% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $13.00 | Low | View details for HC Wainwright rating of Eledon Pharmaceuticals (NASDAQ:ELDN) on 3/22/2024 |
LYRA Lyra Therapeutics | $6.22 -4.7% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Lyra Therapeutics (NASDAQ:LYRA) on 3/22/2024 |
NKTX Nkarta | $10.81 -2.5% | 3/22/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $22.00 -> $20.00 | Low | View details for HC Wainwright rating of Nkarta (NASDAQ:NKTX) on 3/22/2024 |
BRNS Barinthus Biotherapeutics | $2.38 +2.1% | 3/21/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $15.00 -> $8.00 | Low | View details for HC Wainwright rating of Barinthus Biotherapeutics (NASDAQ:BRNS) on 3/21/2024 |
CNTX Context Therapeutics | $1.39 +0.6% | 3/21/2024 | Target Lowered by | HC Wainwright | Analyst E. Bodnar | Buy -> Buy | $5.00 -> $4.00 | Low | View details for HC Wainwright rating of Context Therapeutics (NASDAQ:CNTX) on 3/21/2024 |
INKT MiNK Therapeutics | $0.92 +1.0% | 3/21/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $10.00 -> $9.00 | Low | View details for HC Wainwright rating of MiNK Therapeutics (NASDAQ:INKT) on 3/21/2024 |
OABI OmniAb | $5.42 +0.6% | 3/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of OmniAb (NASDAQ:OABI) on 3/21/2024 |
CMPX Compass Therapeutics | $1.98 -3.4% | 3/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Compass Therapeutics (NASDAQ:CMPX) on 3/21/2024 |
KOPN Kopin | $1.80 -2.7% | 3/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of Kopin (NASDAQ:KOPN) on 3/21/2024 |
CLDI Calidi Biotherapeutics | $0.57 -0.5% | 3/21/2024 | Target Lowered by | HC Wainwright | Analyst R. Burns | Buy -> Buy | $11.00 -> $2.00 | N/A | View details for HC Wainwright rating of Calidi Biotherapeutics (NYSEAMERICAN:CLDI) on 3/21/2024 |
CLDI Calidi Biotherapeutics | $0.57 -0.4% | 3/21/2024 | Target Lowered by | HC Wainwright | Analyst R. Burns | Buy -> Buy | $11.00 -> $2.00 | N/A | View details for HC Wainwright rating of Calidi Biotherapeutics (NYSEAMERICAN:CLDI) on 3/21/2024 |
LVTX LAVA Therapeutics | $3.33 -14.8% | 3/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of LAVA Therapeutics (NASDAQ:LVTX) on 3/21/2024 |
ORIC ORIC Pharmaceuticals | $13.75 +2.1% | 3/21/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $15.00 -> $21.00 | Low | View details for HC Wainwright rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 3/21/2024 |
Crypto Market Preps For Trillions Worth of Inflows! (Ad) Bitcoin is rapidly approaching new ALL-TIME HIGHS…
The market is buzzing after recent approval of spot Bitcoin exchange-traded funds (ETF).
Top analysts predict these ETFs will attract trillions of dollars worth of inflows over the next few years…
And as Bitcoin rallies, we could see other smaller coins rise to heights never seen before. Click to join the Crypto Community Summit Free Online Event |
VZLA Vizsla Silver | $1.33 +4.7% | 3/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.25 | Low | View details for HC Wainwright rating of Vizsla Silver (NYSE:VZLA) on 3/21/2024 |
ANVS Annovis Bio | $11.90 -1.1% | 3/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of Annovis Bio (NYSE:ANVS) on 3/21/2024 |
HLVX HilleVax | $16.60 +6.3% | 3/21/2024 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $28.00 | Low | View details for HC Wainwright rating of HilleVax (NASDAQ:HLVX) on 3/21/2024 |
FEMY Femasys | $1.55 +5.4% | 3/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 3/21/2024 |
ANIX Anixa Biosciences | $3.12 -3.4% | 3/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Anixa Biosciences (NASDAQ:ANIX) on 3/21/2024 |
MOGO Mogo | $2.00 +5.8% | 3/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of Mogo (NASDAQ:MOGO) on 3/21/2024 |
VALN Valneva | $7.92 -0.4% | 3/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $26.00 | Low | View details for HC Wainwright rating of Valneva (NASDAQ:VALN) on 3/21/2024 |
VOR Vor Biopharma | $2.37 +7.2% | 3/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.50 | Low | View details for HC Wainwright rating of Vor Biopharma (NYSE:VOR) on 3/21/2024 |
SYBX Synlogic | $1.79 +0.6% | 3/20/2024 | Upgraded by | HC Wainwright | Analyst E. Arce | Sell -> Neutral | | Low | View details for HC Wainwright rating of Synlogic (NASDAQ:SYBX) on 3/20/2024 |
SLRN Acelyrin | $6.75
| 3/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of Acelyrin (NASDAQ:SLRN) on 3/20/2024 |
ACET Adicet Bio | $2.35 +0.9% | 3/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Adicet Bio (NASDAQ:ACET) on 3/20/2024 |
LUMO Lumos Pharma | $2.82
| 3/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $28.00 | Low | View details for HC Wainwright rating of Lumos Pharma (NASDAQ:LUMO) on 3/20/2024 |
IVA Inventiva | $3.62 -5.2% | 3/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $22.00 | Low | View details for HC Wainwright rating of Inventiva (NASDAQ:IVA) on 3/20/2024 |
BTBT Bit Digital | $2.87 +14.8% | 3/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 | Low | View details for HC Wainwright rating of Bit Digital (NASDAQ:BTBT) on 3/20/2024 |
MAG MAG Silver | $10.58 +7.1% | 3/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $19.50 -> $18.50 | N/A | View details for HC Wainwright rating of MAG Silver (NYSEAMERICAN:MAG) on 3/20/2024 |
MITK Mitek Systems | $14.10 +1.3% | 3/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $19.00 | Low | View details for HC Wainwright rating of Mitek Systems (NASDAQ:MITK) on 3/20/2024 |
TPST Tempest Therapeutics | $3.91 +5.4% | 3/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $47.00 | Low | View details for HC Wainwright rating of Tempest Therapeutics (NASDAQ:TPST) on 3/20/2024 |
TYRA Tyra Biosciences | $16.40 +0.6% | 3/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $19.00 -> $23.00 | Low | View details for HC Wainwright rating of Tyra Biosciences (NASDAQ:TYRA) on 3/20/2024 |
ARCT Arcturus Therapeutics | $33.77 +2.8% | 3/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $60.00 | Low | View details for HC Wainwright rating of Arcturus Therapeutics (NASDAQ:ARCT) on 3/20/2024 |
AXSM Axsome Therapeutics | $79.80 +0.8% | 3/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $180.00 | Low | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 3/20/2024 |
TRML Tourmaline Bio | $22.90
| 3/20/2024 | Reiterated by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $48.00 | Low | View details for HC Wainwright rating of Tourmaline Bio (NASDAQ:TRML) on 3/20/2024 |
COCP Cocrystal Pharma | $1.41 -6.0% | 3/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Cocrystal Pharma (NASDAQ:COCP) on 3/20/2024 |
PGEN Precigen | $1.45
| 3/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of Precigen (NASDAQ:PGEN) on 3/20/2024 |
EVAX Evaxion Biotech A/S | $3.20 +6.7% | 3/20/2024 | Reiterated by | HC Wainwright | Analyst S. Ramakanth | Buy -> Buy | $14.00 | Low | View details for HC Wainwright rating of Evaxion Biotech A/S (NASDAQ:EVAX) on 3/20/2024 |
TNGX Tango Therapeutics | $7.94 +3.1% | 3/20/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $16.00 -> $17.00 | Low | View details for HC Wainwright rating of Tango Therapeutics (NASDAQ:TNGX) on 3/20/2024 |
ICCM IceCure Medical | $1.20 +0.8% | 3/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of IceCure Medical (NASDAQ:ICCM) on 3/20/2024 |
CHRS Coherus BioSciences | $2.38 -1.7% | 3/20/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $13.00 -> $11.00 | Low | View details for HC Wainwright rating of Coherus BioSciences (NASDAQ:CHRS) on 3/20/2024 |
BTM Bitcoin Depot | $1.90 -0.5% | 3/19/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $6.00 -> $5.00 | Low | View details for HC Wainwright rating of Bitcoin Depot (NASDAQ:BTM) on 3/19/2024 |
CRNX Crinetics Pharmaceuticals | $46.78 +5.3% | 3/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | Low | View details for HC Wainwright rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 3/19/2024 |
SRRK Scholar Rock | $17.76 +15.0% | 3/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of Scholar Rock (NASDAQ:SRRK) on 3/19/2024 |
ATNM Actinium Pharmaceuticals | $7.83 -1.4% | 3/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | N/A | View details for HC Wainwright rating of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) on 3/19/2024 |
FURY Fury Gold Mines | $0.42 +2.8% | 3/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $1.50 | N/A | View details for HC Wainwright rating of Fury Gold Mines (NYSEAMERICAN:FURY) on 3/19/2024 |
NAK Northern Dynasty Minerals | $0.32 +2.7% | 3/19/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $0.90 -> $0.80 | N/A | View details for HC Wainwright rating of Northern Dynasty Minerals (NYSEAMERICAN:NAK) on 3/19/2024 |
MARA Marathon Digital | $22.58 +2.3% | 3/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $35.00 | Low | View details for HC Wainwright rating of Marathon Digital (NASDAQ:MARA) on 3/19/2024 |
SGMO Sangamo Therapeutics | $0.67 +7.3% | 3/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 -> $5.00 | Low | View details for HC Wainwright rating of Sangamo Therapeutics (NASDAQ:SGMO) on 3/19/2024 |
CRBU Caribou Biosciences | $5.14 +0.4% | 3/19/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $23.00 -> $24.00 | Low | View details for HC Wainwright rating of Caribou Biosciences (NASDAQ:CRBU) on 3/19/2024 |
ALPN Alpine Immune Sciences | $39.64 +2.6% | 3/19/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $32.00 -> $50.00 | Low | View details for HC Wainwright rating of Alpine Immune Sciences (NASDAQ:ALPN) on 3/19/2024 |
ACXP Acurx Pharmaceuticals | $2.45 +5.2% | 3/19/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $14.00 -> $12.00 | Low | View details for HC Wainwright rating of Acurx Pharmaceuticals (NASDAQ:ACXP) on 3/19/2024 |
NGNE Neurogene | $50.90 +3.3% | 3/19/2024 | Target Raised by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $45.00 -> $55.00 | Low | View details for HC Wainwright rating of Neurogene (NASDAQ:NGNE) on 3/19/2024 |
VSTM Verastem | $11.80 -0.2% | 3/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.50 | Low | View details for HC Wainwright rating of Verastem (NASDAQ:VSTM) on 3/19/2024 |
LPTX Leap Therapeutics | $2.66 -4.3% | 3/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Leap Therapeutics (NASDAQ:LPTX) on 3/19/2024 |
VYGR Voyager Therapeutics | $9.31 -2.6% | 3/19/2024 | Initiated by | HC Wainwright | Analyst P. Trucchio | Buy | $30.00 | Low | View details for HC Wainwright rating of Voyager Therapeutics (NASDAQ:VYGR) on 3/19/2024 |
FATE Fate Therapeutics | $7.34
| 3/19/2024 | Reiterated by | HC Wainwright | - | Neutral | $7.00 | Low | View details for HC Wainwright rating of Fate Therapeutics (NASDAQ:FATE) on 3/19/2024 |
ALLO Allogene Therapeutics | $4.45 -0.2% | 3/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Allogene Therapeutics (NASDAQ:ALLO) on 3/19/2024 |
EYEN Eyenovia | $0.99 +0.4% | 3/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Eyenovia (NASDAQ:EYEN) on 3/19/2024 |
IKNA Ikena Oncology | $1.42 +2.2% | 3/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of Ikena Oncology (NASDAQ:IKNA) on 3/19/2024 |
TNYA Tenaya Therapeutics | $5.23 +1.4% | 3/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 | Low | View details for HC Wainwright rating of Tenaya Therapeutics (NASDAQ:TNYA) on 3/19/2024 |
BLTE Belite Bio | $38.37 -3.9% | 3/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $59.00 | Low | View details for HC Wainwright rating of Belite Bio (NASDAQ:BLTE) on 3/13/2024 |
ITRG Integra Resources | $0.71 +0.4% | 3/13/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $4.00 -> $3.75 | N/A | View details for HC Wainwright rating of Integra Resources (NYSEAMERICAN:ITRG) on 3/13/2024 |
BITF Bitfarms | $2.23 +3.2% | 3/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 | Low | View details for HC Wainwright rating of Bitfarms (NASDAQ:BITF) on 3/13/2024 |
Buy Friday, Sell Monday, No Exceptions (Ad) Every week traders grind it out Monday through Friday…
But neglect trading Friday to Monday…
Or… “over the weekend”
As one professional trader explains, trading over the weekend is one of the most forgiving strategies you can use today.
It allows him to sidestep a lot of the midweek volatility.
Yet, gives him the opportunity to target some of the markets biggest stock moves.
Just recently, he posted a trade on Nordstrom…
The trade was published at 3pm on a Friday afternoon and by Monday morning the trade more than doubled. And for the first time in 2024, he’s sharing his strategy for free. |
RLYB Rallybio | $1.85 +16.4% | 3/13/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $12.00 -> $9.00 | Low | View details for HC Wainwright rating of Rallybio (NASDAQ:RLYB) on 3/13/2024 |
FTEK Fuel Tech | $1.22
| 3/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 | Low | View details for HC Wainwright rating of Fuel Tech (NASDAQ:FTEK) on 3/13/2024 |
CRNX Crinetics Pharmaceuticals | $46.78 +5.3% | 3/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | Low | View details for HC Wainwright rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 3/13/2024 |
PRTA Prothena | $24.77 -1.6% | 3/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $90.00 | Low | View details for HC Wainwright rating of Prothena (NASDAQ:PRTA) on 3/13/2024 |
INZY Inozyme Pharma | $7.65 +3.5% | 3/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 | Low | View details for HC Wainwright rating of Inozyme Pharma (NASDAQ:INZY) on 3/13/2024 |
PHUN Phunware | $8.96 -7.6% | 3/13/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Phunware (NASDAQ:PHUN) on 3/13/2024 |
TVTX Travere Therapeutics | $7.71 +0.5% | 3/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.00 | Low | View details for HC Wainwright rating of Travere Therapeutics (NASDAQ:TVTX) on 3/13/2024 |
ETNB 89bio | $11.64 +2.9% | 3/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $31.00 | Low | View details for HC Wainwright rating of 89bio (NASDAQ:ETNB) on 3/13/2024 |
CYBN Cybin | $0.41 -3.8% | 3/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 | N/A | View details for HC Wainwright rating of Cybin (NYSEAMERICAN:CYBN) on 3/13/2024 |
CALC CalciMedica | $4.16 -0.7% | 3/13/2024 | Reiterated by | HC Wainwright | Analyst J. Pantginis | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of CalciMedica (NASDAQ:CALC) on 3/13/2024 |
IMNN Imunon | $1.64 +17.1% | 3/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Imunon (NASDAQ:IMNN) on 3/13/2024 |
CLNN Clene | $0.43 +1.2% | 3/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Clene (NASDAQ:CLNN) on 3/13/2024 |
SGMO Sangamo Therapeutics | $0.67 +7.3% | 3/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of Sangamo Therapeutics (NASDAQ:SGMO) on 3/13/2024 |
MOGO Mogo | $2.00 +5.8% | 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of Mogo (NASDAQ:MOGO) on 3/14/2024 |
MIRM Mirum Pharmaceuticals | $25.12
| 3/14/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $45.00 -> $58.00 | Low | View details for HC Wainwright rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 3/14/2024 |
UNCY Unicycive Therapeutics | $1.38 -5.5% | 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.50 | Low | View details for HC Wainwright rating of Unicycive Therapeutics (NASDAQ:UNCY) on 3/14/2024 |
ECOR electroCore | $6.17 +5.1% | 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | | Low | View details for HC Wainwright rating of electroCore (NASDAQ:ECOR) on 3/14/2024 |
CLSD Clearside Biomedical | $1.53 -8.4% | 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of Clearside Biomedical (NASDAQ:CLSD) on 3/14/2024 |
TARA Protara Therapeutics | $4.01 +0.3% | 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $23.00 | Low | View details for HC Wainwright rating of Protara Therapeutics (NASDAQ:TARA) on 3/14/2024 |
ATXS Astria Therapeutics | $14.07 +3.5% | 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 | Low | View details for HC Wainwright rating of Astria Therapeutics (NASDAQ:ATXS) on 3/14/2024 |
PRQR ProQR Therapeutics | $2.29 -3.8% | 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 | Low | View details for HC Wainwright rating of ProQR Therapeutics (NASDAQ:PRQR) on 3/14/2024 |
MNMD Mind Medicine (MindMed) | $9.40 -1.1% | 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $75.00 | Low | View details for HC Wainwright rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 3/14/2024 |
SCPH scPharmaceuticals | $5.02 -0.2% | 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 | Low | View details for HC Wainwright rating of scPharmaceuticals (NASDAQ:SCPH) on 3/14/2024 |
JAZZ Jazz Pharmaceuticals | $120.42 -0.1% | 3/14/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $204.00 -> $200.00 | Low | View details for HC Wainwright rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 3/14/2024 |
SLDB Solid Biosciences | $13.32 -6.5% | 3/14/2024 | Reiterated by | HC Wainwright | Analyst A. He | Buy -> Buy | $16.00 | Low | View details for HC Wainwright rating of Solid Biosciences (NASDAQ:SLDB) on 3/14/2024 |
CVKD Cadrenal Therapeutics | $0.63 -1.6% | 3/14/2024 | Reiterated by | HC Wainwright | Analyst J. Pantginis | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of Cadrenal Therapeutics (NASDAQ:CVKD) on 3/14/2024 |
CHRS Coherus BioSciences | $2.38 -1.7% | 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $13.00 | Low | View details for HC Wainwright rating of Coherus BioSciences (NASDAQ:CHRS) on 3/14/2024 |
KRTX Karuna Therapeutics | $329.83 +0.0% | 3/14/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Neutral -> Neutral | $330.00 | N/A | View details for HC Wainwright rating of Karuna Therapeutics (NASDAQ:KRTX) on 3/14/2024 |
AGEN Agenus | $0.57 +2.4% | 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 3/14/2024 |
LQDA Liquidia | $14.75 -2.1% | 3/14/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $16.00 -> $32.00 | Low | View details for HC Wainwright rating of Liquidia (NASDAQ:LQDA) on 3/14/2024 |
FTCI FTC Solar | $0.54 -8.4% | 3/14/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $2.50 -> $1.50 | Low | View details for HC Wainwright rating of FTC Solar (NASDAQ:FTCI) on 3/14/2024 |
PHAR Pharming Group | $10.84 -0.1% | 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $37.00 | Low | View details for HC Wainwright rating of Pharming Group (NASDAQ:PHAR) on 3/14/2024 |
CGEM Cullinan Oncology | $17.07 -3.7% | 3/14/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $34.00 | Low | View details for HC Wainwright rating of Cullinan Oncology (NASDAQ:CGEM) on 3/14/2024 |
KOPN Kopin | $1.80 -2.7% | 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of Kopin (NASDAQ:KOPN) on 3/15/2024 |
INAB IN8bio | $1.18 -2.5% | 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 | Low | View details for HC Wainwright rating of IN8bio (NASDAQ:INAB) on 3/15/2024 |
VKTX Viking Therapeutics | $82.00 -1.6% | 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $90.00 | Low | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 3/15/2024 |
LIFE aTyr Pharma | $1.95 -2.5% | 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $35.00 | N/A | View details for HC Wainwright rating of aTyr Pharma (NASDAQ:LIFE) on 3/15/2024 |
TERN Terns Pharmaceuticals | $6.56 +6.5% | 3/15/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | $5.50 | N/A | View details for HC Wainwright rating of Terns Pharmaceuticals (NASDAQ:TERN) on 3/15/2024 |
AKBA Akebia Therapeutics | $1.83 -18.3% | 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 | N/A | View details for HC Wainwright rating of Akebia Therapeutics (NASDAQ:AKBA) on 3/15/2024 |
IPSC Century Therapeutics | $4.18 -2.1% | 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $13.00 | N/A | View details for HC Wainwright rating of Century Therapeutics (NASDAQ:IPSC) on 3/15/2024 |
CTSO Cytosorbents | $0.95 +2.2% | 3/15/2024 | Reiterated by | HC Wainwright | Analyst S. Lee | Neutral -> Neutral | $1.00 | N/A | View details for HC Wainwright rating of Cytosorbents (NASDAQ:CTSO) on 3/15/2024 |
ACIU AC Immune | $2.97 -2.0% | 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 | N/A | View details for HC Wainwright rating of AC Immune (NASDAQ:ACIU) on 3/15/2024 |
KZR Kezar Life Sciences | $0.90 -0.2% | 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | N/A | View details for HC Wainwright rating of Kezar Life Sciences (NASDAQ:KZR) on 3/15/2024 |
CODX Co-Diagnostics | $1.12 +0.9% | 3/15/2024 | Target Lowered by | HC Wainwright | - | Neutral -> Neutral | $3.00 -> $2.50 | N/A | View details for HC Wainwright rating of Co-Diagnostics (NASDAQ:CODX) on 3/15/2024 |
MDGL Madrigal Pharmaceuticals | $267.04 +3.2% | 3/15/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $405.00 -> $425.00 | N/A | View details for HC Wainwright rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 3/15/2024 |
GORO Gold Resource | $0.43 +8.4% | 3/15/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $1.75 -> $1.50 | N/A | View details for HC Wainwright rating of Gold Resource (NYSE:GORO) on 3/15/2024 |
VGZ Vista Gold | $0.56 +5.6% | 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.50 | N/A | View details for HC Wainwright rating of Vista Gold (NYSE:VGZ) on 3/15/2024 |
IPA ImmunoPrecise Antibodies | $1.51 -3.8% | 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 | N/A | View details for HC Wainwright rating of ImmunoPrecise Antibodies (NASDAQ:IPA) on 3/15/2024 |
VIR Vir Biotechnology | $10.13 +0.3% | 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $110.00 | N/A | View details for HC Wainwright rating of Vir Biotechnology (NASDAQ:VIR) on 3/15/2024 |
LBPH Longboard Pharmaceuticals | $21.60 +3.0% | 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $60.00 | Low | View details for HC Wainwright rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 3/15/2024 |
Altcoin FRENZY Alert… (Ad) Bitcoin recently crossed the highest price in its 15-year history…
Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen!
Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days…
Like Fetch.ai, that gained over 350% in just the last 30 days…
Click here now to register for the event (FOR FREE!) |
SLN Silence Therapeutics | $21.60 -1.0% | 3/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $75.00 | Low | View details for HC Wainwright rating of Silence Therapeutics (NASDAQ:SLN) on 3/15/2024 |
TRDA Entrada Therapeutics | $14.17 -1.3% | 3/18/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Entrada Therapeutics (NASDAQ:TRDA) on 3/18/2024 |
LEGN Legend Biotech | $56.09 -1.5% | 3/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $87.00 | Low | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 3/18/2024 |
IMAB I-Mab | $1.86 -0.5% | 3/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 -> $8.00 | Low | View details for HC Wainwright rating of I-Mab (NASDAQ:IMAB) on 3/18/2024 |
BDTX Black Diamond Therapeutics | $5.07 +3.5% | 3/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $12.00 | Low | View details for HC Wainwright rating of Black Diamond Therapeutics (NASDAQ:BDTX) on 3/18/2024 |
AQST Aquestive Therapeutics | $4.26 +3.9% | 3/18/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $7.00 -> $9.00 | Low | View details for HC Wainwright rating of Aquestive Therapeutics (NASDAQ:AQST) on 3/18/2024 |
URGN UroGen Pharma | $15.00 +0.3% | 3/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $54.00 | Low | View details for HC Wainwright rating of UroGen Pharma (NASDAQ:URGN) on 3/18/2024 |
BTAI BioXcel Therapeutics | $2.82 -2.1% | 3/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of BioXcel Therapeutics (NASDAQ:BTAI) on 3/18/2024 |
OPTN OptiNose | $1.46 -1.4% | 3/18/2024 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $5.00 | Low | View details for HC Wainwright rating of OptiNose (NASDAQ:OPTN) on 3/18/2024 |
RGLS Regulus Therapeutics | $2.88
| 3/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 | Low | View details for HC Wainwright rating of Regulus Therapeutics (NASDAQ:RGLS) on 3/18/2024 |
SPRO Spero Therapeutics | $1.72 -1.7% | 3/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Spero Therapeutics (NASDAQ:SPRO) on 3/18/2024 |
ASLN ASLAN Pharmaceuticals | $0.62 -2.5% | 3/18/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $17.00 -> $9.00 | Low | View details for HC Wainwright rating of ASLAN Pharmaceuticals (NASDAQ:ASLN) on 3/18/2024 |
RNAC Cartesian Therapeutics | $0.65 -1.6% | 3/18/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $2.00 | Low | View details for HC Wainwright rating of Cartesian Therapeutics (NASDAQ:RNAC) on 3/18/2024 |
BLNK Blink Charging | $3.00 +0.7% | 3/18/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $25.00 -> $15.00 | Low | View details for HC Wainwright rating of Blink Charging (NASDAQ:BLNK) on 3/18/2024 |
BWAY BrainsWay | $5.29 +0.8% | 3/11/2024 | Reiterated by | HC Wainwright | Analyst B. Pachaiyappan | Buy | | Low | View details for HC Wainwright rating of BrainsWay (NASDAQ:BWAY) on 3/11/2024 |
SPRB Spruce Biosciences | $0.79 +6.2% | 3/14/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Neutral | | Low | View details for HC Wainwright rating of Spruce Biosciences (NASDAQ:SPRB) on 3/14/2024 |
RGNX REGENXBIO | $21.07 -5.0% | 3/11/2024 | Reiterated by | HC Wainwright | Analyst Y. Chen | Buy | $36.00 | Low | View details for HC Wainwright rating of REGENXBIO (NASDAQ:RGNX) on 3/11/2024 |
OPTN OptiNose | $1.46 -1.4% | 3/11/2024 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy | $5.00 | Low | View details for HC Wainwright rating of OptiNose (NASDAQ:OPTN) on 3/11/2024 |
AEYE AudioEye | $10.04 -2.0% | 3/7/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $8.00 -> $10.00 | Low | View details for HC Wainwright rating of AudioEye (NASDAQ:AEYE) on 3/7/2024 |
URG Ur-Energy | $1.60 +1.3% | 3/7/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $2.70 -> $3.60 | N/A | View details for HC Wainwright rating of Ur-Energy (NYSEAMERICAN:URG) on 3/7/2024 |
NUVB Nuvation Bio | $3.64 -8.3% | 3/7/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $4.50 -> $5.00 | Low | View details for HC Wainwright rating of Nuvation Bio (NYSE:NUVB) on 3/7/2024 |
PHGE BiomX | $0.45 +26.4% | 3/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.00 | N/A | View details for HC Wainwright rating of BiomX (NYSEAMERICAN:PHGE) on 3/7/2024 |
PMVP PMV Pharmaceuticals | $1.70 +3.0% | 3/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 | Low | View details for HC Wainwright rating of PMV Pharmaceuticals (NASDAQ:PMVP) on 3/7/2024 |
TLPH Talphera | $1.03 -6.4% | 3/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of Talphera (NASDAQ:TLPH) on 3/7/2024 |
HTOO Fusion Fuel Green | $1.69 -0.6% | 3/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.50 | Low | View details for HC Wainwright rating of Fusion Fuel Green (NASDAQ:HTOO) on 3/7/2024 |
SDIG Stronghold Digital Mining | $4.15 +7.8% | 3/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Stronghold Digital Mining (NASDAQ:SDIG) on 3/7/2024 |
WVE Wave Life Sciences | $6.17 +2.2% | 3/7/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $8.00 -> $15.00 | Low | View details for HC Wainwright rating of Wave Life Sciences (NASDAQ:WVE) on 3/7/2024 |
ITOS iTeos Therapeutics | $13.64 +3.6% | 3/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $44.00 | N/A | View details for HC Wainwright rating of iTeos Therapeutics (NASDAQ:ITOS) on 3/7/2024 |
XERS Xeris Biopharma | $2.21 +8.3% | 3/7/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $5.50 -> $6.00 | N/A | View details for HC Wainwright rating of Xeris Biopharma (NASDAQ:XERS) on 3/7/2024 |
RZLT Rezolute | $2.55 +13.8% | 3/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 | N/A | View details for HC Wainwright rating of Rezolute (NASDAQ:RZLT) on 3/7/2024 |
KMDA Kamada | $5.61 +0.2% | 3/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | N/A | View details for HC Wainwright rating of Kamada (NASDAQ:KMDA) on 3/7/2024 |
TCRX TScan Therapeutics | $7.94 -4.3% | 3/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 | N/A | View details for HC Wainwright rating of TScan Therapeutics (NASDAQ:TCRX) on 3/7/2024 |
ELEV Elevation Oncology | $5.11 +2.0% | 3/7/2024 | Reiterated by | HC Wainwright | Analyst S. Ramakanth | Buy -> Buy | $6.00 | N/A | View details for HC Wainwright rating of Elevation Oncology (NASDAQ:ELEV) on 3/7/2024 |
BWEN Broadwind | $2.41 +2.1% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of Broadwind (NASDAQ:BWEN) on 3/6/2024 |
DYN Dyne Therapeutics | $28.39 -0.4% | 3/6/2024 | Reiterated by | HC Wainwright | Analyst A. Fein | Buy -> Buy | $36.00 | Low | View details for HC Wainwright rating of Dyne Therapeutics (NASDAQ:DYN) on 3/6/2024 |
BMEA Biomea Fusion | $14.93 -2.8% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | Low | View details for HC Wainwright rating of Biomea Fusion (NASDAQ:BMEA) on 3/6/2024 |
KURA Kura Oncology | $21.33 +0.8% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $32.00 | Low | View details for HC Wainwright rating of Kura Oncology (NASDAQ:KURA) on 3/6/2024 |
ITRM Iterum Therapeutics | $1.54 -3.1% | 3/6/2024 | Reiterated by | HC Wainwright | Analyst E. Arce | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of Iterum Therapeutics (NASDAQ:ITRM) on 3/6/2024 |
RIGL Rigel Pharmaceuticals | $1.48 -0.7% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 3/6/2024 |
GOSS Gossamer Bio | $1.18 +0.9% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Gossamer Bio (NASDAQ:GOSS) on 3/6/2024 |
ADCT ADC Therapeutics | $4.49 +6.9% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 | Low | View details for HC Wainwright rating of ADC Therapeutics (NYSE:ADCT) on 3/6/2024 |
EYEN Eyenovia | $0.99 +0.4% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Eyenovia (NASDAQ:EYEN) on 3/6/2024 |
IMCR Immunocore | $65.00 +2.2% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $90.00 | Low | View details for HC Wainwright rating of Immunocore (NASDAQ:IMCR) on 3/6/2024 |
IOBT IO Biotech | $1.75 +1.2% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of IO Biotech (NASDAQ:IOBT) on 3/6/2024 |
GRTS Gritstone bio | $2.57 -8.2% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Gritstone bio (NASDAQ:GRTS) on 3/6/2024 |
SWTX SpringWorks Therapeutics | $49.22 -1.8% | 3/6/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $73.00 -> $74.00 | Low | View details for HC Wainwright rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 3/6/2024 |
CECO CECO Environmental | $23.02 +0.1% | 3/6/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $22.00 -> $30.00 | Low | View details for HC Wainwright rating of CECO Environmental (NASDAQ:CECO) on 3/6/2024 |
TCON TRACON Pharmaceuticals | $0.43 +4.8% | 3/6/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $7.00 -> $6.00 | Low | View details for HC Wainwright rating of TRACON Pharmaceuticals (NASDAQ:TCON) on 3/6/2024 |
CRDF Cardiff Oncology | $5.35 -7.0% | 3/6/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $12.00 -> $14.00 | Low | View details for HC Wainwright rating of Cardiff Oncology (NASDAQ:CRDF) on 3/6/2024 |
MRNS Marinus Pharmaceuticals | $9.04 +2.1% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $27.00 | Low | View details for HC Wainwright rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 3/6/2024 |
PRAX Praxis Precision Medicines | $61.02 +3.1% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $105.00 | Low | View details for HC Wainwright rating of Praxis Precision Medicines (NASDAQ:PRAX) on 3/6/2024 |
GMAB Genmab A/S | $29.91 -2.4% | 3/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | Low | View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 3/6/2024 |
YMAB Y-mAbs Therapeutics | $16.26 -1.5% | 3/6/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $21.00 -> $22.00 | Low | View details for HC Wainwright rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 3/6/2024 |
ALNY Alnylam Pharmaceuticals | $149.45 -3.2% | 3/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $395.00 | Low | View details for HC Wainwright rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 3/5/2024 |
PPBT Purple Biotech | $0.67 +9.7% | 3/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Purple Biotech (NASDAQ:PPBT) on 3/5/2024 |
CIFR Cipher Mining | $5.15 -3.4% | 3/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.50 | Low | View details for HC Wainwright rating of Cipher Mining (NASDAQ:CIFR) on 3/5/2024 |
EKSO Ekso Bionics | $1.37 -3.9% | 3/5/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $10.00 -> $9.25 | Low | View details for HC Wainwright rating of Ekso Bionics (NASDAQ:EKSO) on 3/5/2024 |
IKT Inhibikase Therapeutics | $2.16 -6.1% | 3/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $27.00 | Low | View details for HC Wainwright rating of Inhibikase Therapeutics (NYSE:IKT) on 3/5/2024 |
ICCM IceCure Medical | $1.20 +0.8% | 3/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of IceCure Medical (NASDAQ:ICCM) on 3/5/2024 |
NGNE Neurogene | $50.90 +3.3% | 3/5/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $45.00 | Low | View details for HC Wainwright rating of Neurogene (NASDAQ:NGNE) on 3/5/2024 |